CAR T Therapies in Multiple Myeloma: Unleashing the Future

Ongoing preclinical and clinical trials are exploring the capabilities of CAR T cells in targeting specific antigens on myeloma cells, offering hope for patients with relapsed/refractory multiple myeloma.